Evidence map›Paper›PMID 40532855›Full record

ArticleOphthalmology2025

Delayed Rod-Mediated Dark Adaptation Is Associated with Incidence and Early Progression of Age-Related Macular Degeneration: Alabama Study on Early Age-Related Macular Degeneration 2.

Cynthia Owsley, Gerald McGwin, Mark E Clark, Liyan Gao, Lindsay Gooden, Tracy N Thomas, Lukas Goerdt, Christine A Curcio

Erratum issuedAbstract read
In one paragraph

Article in Ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Observational
  3. Article
  4. Impaired Rod-Mediated Vision is the Functional Hallmark of Ageing and Early and Intermediate Age-Related Macular Degeneration.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Cynthia OwsleyDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama. Electronic address: cynthiaowsley@uabmc.edu.
Gerald McGwinDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama; Department of Epidemiology, University of Alabama at Birmingham, Birmingham, Alabama.
Mark E ClarkDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Liyan GaoDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Lindsay GoodenDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Tracy N ThomasDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama.
Lukas GoerdtDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama; Department of Ophthalmology, University of Bonn, Bonn, Germany.
Christine A CurcioDepartment of Ophthalmology and Visual Sciences, University of Alabama at Birmingham, Birmingham, Alabama.

Funding

Visual Phenotyping CoreP30EY003039 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul Douglas Gamlin · 1985 to 2026
$16.9M
Functionally Validated Structural Endpoints for Early AMDR01EY029595 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURCIO, CHRISTINE A, OWSLEY, CYNTHIA · 2019 to 2023
$4.1M
A hyperspectral approach to RPE fluorophores in AMDR01EY027948 · NEI · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI ACH, THOMAS, CURCIO, CHRISTINE A · 2017 to 2025
$3.8M
NEI NIH HHS P30 EY003039NEI NIH HHS R01 EY027948NEI NIH HHS R01 EY029595
6 · The paper itself

Abstract

purposeTo examine whether delayed rod-mediated dark adaptation (RMDA) in healthy older eyes and those with early age-related macular degeneration (AMD) is associated with AMD incidence and progression at follow-up, as compared with other visual functions reliant on rods, cones, or mixed rod-cone mediation.

designLongitudinal study over 3 years.

participantsEyes from adults ≥60 years of age with normal macular health or with early AMD at baseline.

methodsAt baseline, eyes underwent fundus photography to establish AMD presence and severity using the Age-Related Eye Disease Study (AREDS) 9-step classification system. The following visual functions were tested in 1 eye at baseline (the study eye): RMDA, scotopic sensitivity, low-luminance acuity, mesopic contrast sensitivity, mesopic light sensitivity, visual acuity, and contrast sensitivity. Three years later at follow-up, fundus photography and the AREDS classification were repeated. Age-adjusted relative risks and 95% confidence intervals measured the association between visual functions and AMD incidence and progression for the study eye and the fellow eye at follow-up.

main outcome measuresPresence and severity of AMD at the 3-year follow-up visit in the study and fellow eyes.

resultsHealthy older eyes at baseline with delayed RMDA were 3.54 or 3.40 times more likely to have incident AMD at the 3-year follow-up in the study eye and the fellow eye, respectively, compared with eyes without delays. No other visual functions were associated with AMD incidence, except for low-luminance visual acuity in the study eye. Eyes with early AMD at baseline with delayed RMDA were 3.89 or 2.65 times more likely to have progressed at follow-up for the study and fellow eye, respectively. No other visual functions were associated with AMD progression at follow-up.

conclusionsRod-mediated dark adaptation is the only visual function of those tested that was associated with AMD incidence and progression over 3 years in healthy eyes or those with early AMD at baseline. Our results suggest that other visual functions are not useful for understanding AMD incidence and early progression risk. Interventions that eventually are designed to arrest early AMD progression or preventative measures in those at risk should consider RMDA a functional outcome measure. FINANCIAL DISCLOSURE(S): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Dark AdaptationMacular DegenerationRetinal Rod Photoreceptor CellsAgedAged, 80 and overAlabamaContrast SensitivityDisease ProgressionFemaleFollow-Up StudiesHumansIncidenceLongitudinal StudiesMaleMiddle AgedVisual AcuityAge-related macular degenerationIncidenceProgressionRod-mediated dark adaptation

Identifiers

PMID40532855
PMCPMC12377478

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.